Market Research Logo

Global Liquid Biopsy Market Forecast 2018-2026

Global Liquid Biopsy Market Forecast 2018-2026

KEY FINDINGS

Developments in precision medicines, increasing prevalence of cancer cases in the elderly population and supportive government initiatives are factors that are contributing to the expansion of the Liquid –Biopsy market. Over the forecast period of 2018-2026, the global liquid biopsy market is expected to rise at a CAGR of 22.97%.

MARKET INSIGHTS

The Global Liquid Biopsy market is segmented into Biomarker types, Indication, Analysis Platform, Products, Analysis purpose, and End users. The biomarker types include nucleic acids, proteins, extracellular vesicles and cells. The Indication segment of the market can further be classified cancer indications, NIPT, and Transplant. The analysis platform of this market includes Microarray, NGS, Proteomics, PCR, and other analysis platform. The products for this market can be further classified into exosomes, CTCS and CTDNA products. The Analysis purpose for this market is for Therapy guidance, early detection/screening, monitoring and diagnosis. The end-users for this market are Hospitals, Physicians ‘office laboratories’, and Clinical diagnostic laboratories.

REGIONAL INSIGHTS

The regional segmentation of the market is done into Europe, Asia-Pacific, North America, and rest of the world. The Asia-Pacific liquid biopsy market is predicted to exhibit the fastest growth in the global market. Several vendors are favouring this market due to easy availability of cheap labour, low raw-materials cost and a large patient pool. The North American market is forecasted to dominate the global liquid biopsy market in the coming years owing to several technological advances in biopsy technologies. Canada and the US are the major contributors to this market.

COMPETITIVE INSIGHTS

Some of the leading market players in the global liquid biopsy market are Agilent Technologies Inc, Ad-Tech Medical Instrument Corp, Argon Medical Devices Inc, Becton, B. Braun Melsungen Ag, Dickinson, Bio-Rad Laboratories Inc, Boston Scientific Corporation, C. R. Bard, Inc, Cook Group Inc, Cintec Medical Ltd, Fischer Medical Technologies Llc, Planmeca Oy, I.M.S. Internazionale Medico Scientifica Srl,Roche Diagnostics Ltd, and Qiagen N.V.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Cell-free Dna (Cfdna) And Circulating Tumor Dna (Ctdna) Are Key Biomarkers For Liquid Biopsy Tests
3.2.2. Nipt Indication Holds The Largest Market Share
3.2.3. Pcr Isthe Faster Growing Analysis Platform
3.2.4. Early Detection/Screening Analysis Constitutes The Bigger Market
3.2.5. North America Holds The Largest Market Share In The Global Biopsy Market
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Government Initiatives
4.1.2. Growing Pervasiveness Of Cancer Cases In Older Populace
4.1.3. Growing Number Of Diagnostic Centers
4.1.4. Growth Of Precision Medicine
4.1.5. Emergence Of Tissue/Tumor-agnostic Drugs
4.2. Market Restraints
4.2.1. Lack Of A Consensus On Standard Operating Procedures (Sops)
4.2.2. Poor Compensation Structures
4.3. Market Opportunities
4.3.1. Technological Advancement
4.3.2. Growing Number Of Cancer Patients
4.4. Market Challenges
4.4.1. Lack Of Reimbursement
4.4.2. Lack Of Skilled Professionals
5. Market Segmentations
5.1. Market By Products 2018-2026
5.1.1. Ctcs And Ctdna
5.1.2. Exosome
5.2. Market By Analysis Purpose 2018-2026
5.2.1. Early Detection/Screening
5.2.2. Therapy Guidance
5.2.3. Monitoring
5.2.4. Diagnosis
5.3. Market By End User 2018-2026
5.3.1. Physician’s ‘office Laboratories’
5.3.2. Hospitals
5.3.3. Clinical Diagnostic Laboratories
5.4. Market By Analysis Platform 2018-2026
5.4.1. Ngs
5.4.2. Microarray
5.4.3. Pcr
5.4.4. Proteomics
5.4.5. Other Analysis Platform
5.5. Market By Biomarker Types 2018-2026
5.5.1. Nucleic Acids
5.5.2. Proteins
5.5.3. Extracellular Vesicles
5.5.4. Cells
5.6. Market By Indication 2018-2026
5.6.1. Nipt
5.6.2. Cancer
5.6.2.1. Cancer Types
5.6.2.1.1. Pan-cancer
5.6.2.1.2. Lung
5.6.2.1.3. Gynecologic
5.6.2.1.4. Bladder
5.6.2.1.5. Prostate
5.6.2.1.6. Breast
5.6.2.1.7. Hematological
5.6.2.1.8. Colorectal
5.6.2.1.9. Brain
5.6.2.1.10. Gist (Gastrointestinal Stromal Tumors)
5.6.2.1.11. Kidney
5.6.2.1.12. Melanoma
5.6.2.1.13. Pancreatic
5.6.2.1.14. Thyroid
5.6.2.2. Cancer Analysis Purpose
5.6.2.2.1. Therapy Guidance
5.6.2.2.2. Monitoring
5.6.2.2.3. Diagnosis
5.6.2.2.4. Early Detection/Screening
5.6.2.3. Cancer Analysis Method
5.6.2.3.1. Ngs
5.6.2.3.2. Pcr
5.6.2.3.3. Proteomics
5.6.2.3.4. Microarray
5.6.3. Transplant
6. Key Analytics
6.1. Porter’s Five Forces Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitutes
6.1.3. Bargaining Power Of Buyers
6.1.4. Bargaining Power Of Suppliers
6.1.5. Threat Of Rivalry
6.2. Liquid Biopsy Pipeline
6.3. Patent Analysis
6.4. Market Trends
6.4.1. New Players Approach Venture Capitalists To Enter Into Niche Markets
6.4.2. Direct-to-consumer Testing
6.5. Key Liquid Biopsy Initiatives
7. Geography Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Spain
7.2.6. Russia
7.2.7. Rest Of Europe
7.3. Asia-pacific
7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. South Korea
7.3.5. Rest Of Apac
7.4. Rest Of World
7.4.1. Middle East And North Africa (Mena)
7.4.2. Latin America
8. Company Profiles
8.1. Competitive Landscape
8.1.1. List Of Acquisitions
8.1.2. Strategic Alliances
8.2. Ad-tech Medical Instrument Corp
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Swot Analysis
8.3. Agilent Technologies, Inc.
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Argon Medical Devices Inc
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Swot Analysis
8.4.4. Strategic Initiatives
8.5. B. Braun Melsungen Ag
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Swot Analysis
8.5.4. Strategic Initiatives
8.6. Becton, Dickinson
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Swot Analysis
8.6.4. Strategic Initiatives
8.7. Boston Scientific Corporation
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Swot Analysis
8.7.4. Strategic Initiatives
8.8. Bio-rad Laboratories, Inc.
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiative
8.9. C. R. Bard, Inc.
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Swot Analysis
8.9.4. Strategic Initiatives
8.10. Cintec Medical Ltd
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Swot Analysis
8.11. Cook Group Inc
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Swot Analysis
8.11.4. Strategic Initiatives
8.12. Fischer Medical Technologies Llc
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. I.M.S. Internazionale Medico Scientifica Srl
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Swot Analysis
8.14. Planmeca Oy
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Swot Analysis
8.14.4. Strategic Initiatives
8.15. Roche Diagnostics Ltd
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
8.16. Qiagen N.V.
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiatives
Table List
Table 1 Global Liquid Biopsy Market By Geography 2018-2026 ($ Million)
Table 2 Liquid Biopsy Biomarker Classes
Table 3 Government Initiatives For Cancer And Liquid Biopsy Testing In Some Countries
Table 4 Global Liquid Biopsy Market By Products 2018-2026 ($ Million)
Table 5 Global Liquid Biopsy Market By Analysis Purpose 2018-2026 ($ Million)
Table 6 Global Liquid Biopsy Market By End User 2018-2026 ($ Million)
Table 7 Global Liquid Biopsy Market By Analysis Platform 2018-2026 ($ Million)
Table 8 Next-generation Sequencing Instrument Companies
Table 9 Advantages Of Droplet Digital Pcr For Single-cell Analysis
Table 10 Droplet Digital Pcr Industry
Table 11 Global Liquid Biopsy Market By Biomarker Types 2018-2026 ($ Million)
Table 12 Cell Differentiators
Table 13 Global Liquid Biopsy Market By Indication 2018-2026 ($ Million)
Table 14 Global Liquid Biopsy Market In Nipt By Geography 2018-2026 ($ Million)
Table 15 Ethical Issues Associated With Nipt
Table 16 Cell Differentiators
Table 17 Limitations Of Solid Biopsy In Cancer Applications
Table 18 Global Liquid Biopsy Market In Cancer By Geography 2018-2026 ($ Million)
Table 19 Global Cancer Market By Cancer Types 2018-2026 ($ Million)
Table 20 Prostate Cancer Testing Industry
Table 21 Molecular Thyroid Nodule Classifier Test Company Positioning
Table 22 Global Cancer Market By Cancer Analysis Purpose 2018-2026 ($ Million)
Table 23 Early Detection Tissue Of Origin Approaches
Table 24 Global Cancer Market In Cancer Analysis Method 2018-2026 ($ Million)
Table 25 Pipeline Of Liquid Biopsy In North America
Table 26 Pipeline Of Liquid Biopsy In Europe
Table 27 Pipeline Of Liquid Biopsy In Apac
Table 28 Ctc-related Patents
Table 29 Cell-free Dna-related Patents Related Patents
Table 30 Global Liquid Biopsy Market By Geography 2018-2026 ($ Million)
Table 31 North America Liquid Biopsy Market 2018-2026 ($ Million)
Table 32 Europe Liquid Biopsy Market 2018-2026 ($ Million)
Table 33 Asia Pacific Liquid Biopsy Market 2018-2026 ($ Million)
Table 34 Rest Of World Liquid Biopsy Market 2018-2026 ($ Million)
Figures List
Figure 1 Global Liquid Biopsy Market 2018-2026 ($ Million)
Figure 2 Rural Populations In Developing Countries 2017 (%)
Figure 3 Global Liquid Biopsy Market In Ctcs And Ctdna 2018-2026 ($ Million)
Figure 4 Global Liquid Biopsy Market In Exosome 2018-2026 ($ Million)
Figure 5 Global Liquid Biopsy Market In Early Detection/Screening 2018-2026 ($ Million)
Figure 6 Global Liquid Biopsy Market In Therapy Guidance 2018-2026 ($ Million)
Figure 7 Global Liquid Biopsy Market In Monitoring 2018-2026 ($ Million)
Figure 8 Global Liquid Biopsy Market In Diagnosis 2018-2026 ($ Million)
Figure 9 Global Liquid Biopsy Market In Physicians Office Laboratories 2018-2026 ($ Million)
Figure 10 Global Liquid Biopsy Market In Hospitals 2018-2026 ($ Million)
Figure 11 Global Liquid Biopsy Market In Clinical Diagnostic Laboratories 2018-2026 ($ Million)
Figure 12 Global Liquid Biopsy Market In Ngs 2018-2026 ($ Million)
Figure 13 Global Liquid Biopsy Market In Microarray 2018-2026 ($ Million)
Figure 14 Global Liquid Biopsy Market In Pcr 2018-2026 ($ Million)
Figure 15 Global Liquid Biopsy Market In Proteomics 2018-2026 ($ Million)
Figure 16 Global Liquid Biopsy Market In Other Analysis Platform 2018-2026 ($ Million)
Figure 17 Global Liquid Biopsy Market In Nucleic Acids 2018-2026 ($ Million)
Figure 18 Global Liquid Biopsy Market In Proteins 2018-2026 ($ Million)
Figure 19 Global Liquid Biopsy Market In Extracellular Vesicles 2018-2026 ($ Million)
Figure 20 Global Liquid Biopsy Market In Cells 2018-2026 ($ Million)
Figure 21 Global Liquid Biopsy Market In Nipt 2018-2026 ($ Million)
Figure 22 Global Liquid Biopsy Market In Cancer 2018-2026 ($ Million)
Figure 23 Global Cancer Market In Pan-cancer 2018-2026 ($ Million)
Figure 24 Global Cancer Market In Lung 2018-2026 ($ Million)
Figure 25 Global Cancer Market In Gynecologic 2018-2026 ($ Million)
Figure 26 Global Cancer Market In Bladder 2018-2026 ($ Million)
Figure 27 Global Cancer Market In Prostate 2018-2026 ($ Million)
Figure 28 Global Cancer Market In Breast 2018-2026 ($ Million)
Figure 29 Global Cancer Market In Hematological 2018-2026 ($ Million)
Figure 30 Global Cancer Market In Colorectal 2018-2026 ($ Million)
Figure 31 Global Cancer Market In Brain 2018-2026 ($ Million)
Figure 32 Global Cancer Market In Gist (Gastrointestinal Stromal Tumors) 2018-2026 ($ Million)
Figure 33 Global Cancer Market In Kidney 2018-2026 ($ Million)
Figure 34 Global Cancer Market In Melanoma 2018-2026 ($ Million)
Figure 35 Global Cancer Market In Pancreatic 2018-2026 ($ Million)
Figure 36 Global Cancer Market In Thyroid 2018-2026 ($ Million)
Figure 37 Global Cancer Market In Therapy Guidance 2018-2026 ($ Million)
Figure 38 Global Cancer Market In Monitoring 2018-2026 ($ Million)
Figure 39 Global Cancer Market In Diagnosis 2018-2026 ($ Million)
Figure 40 Global Cancer Market In Early Detection/Screening 2018-2026 ($ Million)
Figure 41 Global Cancer Market In Ngs 2018-2026 ($ Million)
Figure 42 Global Cancer Market In Pcr 2018-2026 ($ Million)
Figure 43 Global Cancer Market In Proteomics 2018-2026 ($ Million)
Figure 44 Global Cancer Market In Microarray 2018-2026 ($ Million)
Figure 45 Global Liquid Biopsy Market In Transplant 2018-2026 ($ Million)
Figure 46 North America Liquid Biopsy Market 2018-2026 ($ Million)
Figure 47 The United States Biopsy Market 2018-2026 ($ Million)
Figure 48 New Cancer Cases And Cancer Deaths In The Us 2016-2020 (Per 100,000 Population)
Figure 49 Canada Liquid Biopsy Market 2018-2026 ($ Million)
Figure 50 Europe Liquid Biopsy Market 2018-2026 ($ Million)
Figure 51 The United Kingdom Liquid Biopsy Market 2018-2026 ($ Million)
Figure 52 France Liquid Biopsy Market 2018-2026 ($ Million)
Figure 53 Germany Liquid Biopsy Market 2018-2026 ($ Million)
Figure 54 Italy Liquid Biopsy Market 2018-2026 ($ Million)
Figure 55 Spain Liquid Biopsy Market 2018-2026 ($ Million)
Figure 56 Russia Liquid Biopsy Market 2018-2026 ($ Million)
Figure 57 Rest Of Europe Liquid Biopsy Market 2018-2026 ($ Million)
Figure 58 Asia Pacific Liquid Biopsy Market 2018-2026 ($ Million)
Figure 59 Japan Liquid Biopsy Market 2018-2026 ($ Million)
Figure 60 China Liquid Biopsy Market 2018-2026 ($ Million)
Figure 61 India Liquid Biopsy Market 2018-2026 ($ Million)
Figure 62 South Korea Liquid Biopsy Market 2018-2026 ($ Million)
Figure 63 Rest Of Apac Liquid Biopsy Market 2018-2026 ($ Million)
Figure 64 Rest Of World Liquid Biopsy Market 2018-2026 ($ Million)
Figure 65 Middle East And North Africa Liquid Biopsy Market 2018-2026 ($ Million)
Figure 66 Latin America Biopsy Market 2018-2026 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report